Diabetes Mellitus Flashcards

1
Q

Different criteria for diagnosis of DM (name 4)

A
  1. Fasting glucose greater than 126
  2. Plasma glucose greater than 200 after 2 hour GTT (75 g glucose load)
  3. Any plasma glucose over 200 + symptoms (polydipsia, polyuria, etc)
  4. HbA1c 6.5% or more
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What can you measure to differentiate between T1DM and T2DM

A

C-peptide and insulin levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

When does glucosuria occur?

A

When bood glucose level is greater than renal “threshold”; often at serum level of 180 which corresponds to HbA1c of 8%

So absence of glucose on urinalysis does not exclude DM!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What other physical symptoms are more consistent with T2DM

A

HTN, acanthosis nigracans, obesity…all overt signs of insulin resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Upon initial dx of DM, and regulary after dx, what testing?

A

fasting lipid profile, serum creatinine and creatinine ratio, U/A, urinemicroalbumin, annual dilated eye exams, regular foot exam, ECG and thyroid dx screening with TSH (in T1DM)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

General approach to treatment of DM

A

aimed at secondary prevention of macrovascular (CAD, cerebral/peripheral vascular dx) and microvascular (retinopathy, nephropathy, and neuropathy) complications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pathophysiology of T1DM (aka IDDM)

A

not entirely known, may be autoimmune that attacks pancreatic B cells, thereby rendering body unable to produce insulin…body is then unable to metabolize glucose and carbs, so must resort to metabolizing fats…leading to ketones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

DKA

A

syndrome characterized by hyperglycemia, high levels of serum acetone, b-hydroxybutarate, and anion gap metabolic acidosis

usually happens under stress or when person forgets to take insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Treatment of DKA

A

emergent hospitalization for IV hydration with NS, correction of acidosis and electrolyte disturbances (give K), aggessive insulin mgmt, evaluation for underlying cause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pathophysiology T2DM (NIDDM)

A

insulin resistance in peripheral tissues often due to visceral adiposity and obesity…may have hyperinsulinemia then eventually less insulin
majority of cases, stronger family component

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Comlications of T2DM

A

cardiometabolic syndrome, hyperinsulinemia, HTN, dyslipidemia, hyperglycemia, central obesity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

T2DM less prone to developing ketosis and acidosis, but is more prone to ________ states due to high blood sugar

A

hyperosmolar

aka hyperosmolar hyperglycemic non-ketotic syndrome (HHNS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Characteristics of HHNS

A

blood glucose substantially elevated (often reaching up to 1000), with elevated serum osmolarity and large fluid deficit…severe coma or death may occur due to electrolyte abnormalities, dehydration, and toxic effects of metabolic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How to treat HHNS

A

similar to DKA;

hospitalization, aggresive rehydration, with NS and electrolyte correction; insulin and treatment of underlying disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

GDM (gestational DM)

A

increased levels of human placental lactogen (hpL), estrogen and progesterone produced by placenta antagonize insulin -> insulin resistance and carb intolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Maternal complications of GDM

A

hyperglycemia, DKA, increased UTI, increased HTN/pre-eclampsia, retinopathy

17
Q

Fetal complications of GDM

A

congenital malformations, macrosomia, RDS, hypoglycemia, hyperbilirubinemia, hpocalcemia, polycythemia, and hydramnios

18
Q

What are mothers who have GDM more at risk of after pregnancy and how to mitigate this risk

A

T2DM, should be screened with GTT postpartum and annual diabetic screening

19
Q

When to screen for GDM and how to screen

A

between 24-28 weeks
first with 1hr 50 g GTT….
then if that shows greater than 140, do 3 hr 100g GTT, which takes fasting, 1hr, 2hr, and 3hr measurements…
if 2 or more abnormal values (95,180,155,140)…then that is diagnosis

20
Q

How to treat GDM

A

strict dietary mgmt, and if necessary oral diabetic agents with or without insulin.

21
Q

Once GDM is diagnosed, what must be monitored for during pregnancy

A

Increased surveillance for UFD (uterine fetal demise)

22
Q

Goals to achieve “controlled status” in diabetic patient

A
  • strict glycemic control with goal a1c of less than 7

- LDL

23
Q

Treatment for T1DM

A
  • insulin administration (usually short acting before meals + long acting basal insulin) via injection or pump (if labile sugar)
  • strict glucose monitoring
  • calorie restricted and low carb diet and exercise
24
Q

First line medication of T2DM

A

biguanides (METFORMIN)

25
Q

Biguanide mechanism

A

act on liver to decrease gluocse output during gluconeogenesis.

secondary: improved insulin sensitivity in liver and muscle; possible decrease in intestinal absorption of glucose

26
Q

Other advatnages of metformin

A

no risk of hypoglycemia, good for weight loss, reduced serum insulin levels, reduction in triglycerides and LDL

27
Q

Metformin side effects common and dangerous

A

common: nausea and diarrhea
dangerous: development of lactic acidosis caused by renal insufficency and CKD (contraindication in patients with Cr> 1.4-1.5)

28
Q

Is metformin safe for pregnancy?

A

Yes; Cat B, also good for children older than 10

29
Q

Examples of sulfonlyureas

A

glimepiride glyburide, glipizide

30
Q

Mechanism of sulfonylureas

A

insulin secretagogues that stimulate pancreatic B cells to secrete insulin